MORGAN STANLEY - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 22 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$482,964
-8.4%
75,228
+6.3%
0.00%
Q1 2023$526,990
+2973.4%
70,737
+1702.7%
0.00%
Q4 2022$17,147
+0.9%
3,924
+31.8%
0.00%
Q3 2022$17,000
+6.2%
2,977
+4.5%
0.00%
Q2 2022$16,000
-92.2%
2,850
-85.9%
0.00%
Q1 2022$206,000
+202.9%
20,258
+144.2%
0.00%
Q4 2021$68,000
+15.3%
8,297
+14.3%
0.00%
Q3 2021$59,000
-39.2%
7,261
-60.2%
0.00%
Q2 2021$97,00018,2270.00%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 136,593$1,106,0000.35%
Total Clarity Wealth Management, Inc. 11,425$93,0000.04%
Virtu Financial LLC 32,952$267,0000.02%
Apollon Wealth Management, LLC 19,400$157,0000.02%
Summit Trail Advisors, LLC 35,000$284,0000.02%
FNY Investment Advisers, LLC 4,687$37,0000.02%
Freedom Investment Management, Inc. 16,649$135,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 156,946$1,271,0000.01%
Belvedere Trading LLC 13,608$107,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 10,000$81,0000.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders